03:25 AM EDT, 08/21/2025 (MT Newswires) -- Telix Pharmaceuticals ( TLX ) said Wednesday it has reaffirmed its 2025 revenue guidance of $770 million to $800 million.
Analysts polled by FactSet expect $769.3 million.
The company reported H1 revenue of $390.4 million, up from $239.6 million a year earlier.
Analysts polled by FactSet expected $368.5 million.